Host: Hector O. Chapa, MD Guest: Susan Crowe, MD Both UNICEF and WHO recommend exclusive breastfeeding for the first six months of life, starting within the very first hour of birth. But are we adhering to that recommendation? Joining Dr. Hector Chapa to discuss the importance of breastfeeding shortly after delivery and how we can help our patients and their newborns reap the benefits of this golden hour is Dr. Susan Crowe, Director of Outpatient Breastfeeding Medicine Consultative Services at Stanford Children's Health who recently spoke about this topic at the 2021 ACOG Annual Clinical and Scientific Meeting.

Conference Coverage

Optimizing Breastfeeding Within the Golden Hour

Host: Hector O. Chapa, MD ACOG's Annual Clinical and Scientific Meeting will be held virtually this year, but that doesn't mean the content is any less collaborative and impactful. Listen in to hear what ReachMD's host and practicing OB-GYN, Dr. Hector Chapa, is looking forward to at this year's meeting.

ACOG 2021: What Can We Look Forward to?

Host: Matt Birnholz, MD Guest: Slavica Janeva, MD Despite the increasing number of elderly patients diagnosed with breast cancer, few clinical trials focus on this age group. That’s why Dr. Slavica Janeva's team focused on the impacts of adjuvant chemotherapy on survival rates in this patient population, the results of which may change clinical practice paradigms moving forward, as he discusses with Dr. Matt Birnholz.

Monitoring Adjuvant Chemotherapy in Elderly Women with Triple Negative Breast Cancer

Host: Matt Birnholz, MD Guest: Luka Dobovisek, MD Though cannabidiol (CBD) has long been recognized in the oncological field as a palliative therapeutic agent, only recently has it been demonstrated to induce anti-tumor responses in breast cancer. To learn more, Dr. Matt Birnholz is joined by Dr. Luka Dobovisek, whose recent study looked at the effect of CBD on cell viability of selected breast cancer cell lines, both as a single agent and in combinations with breast cancer therapies such as tamoxifen.

Investigating the Impact of Cannabidiol on Breast Cancer Cell Viability

Guest: C. Kent Osborne, MD After doing breast cancer research for over 40 years, Dr. Kent Osborne has seen a lot of advances in the field, and now he’s here to share his viewpoint on the opportunities and challenges that lie ahead.

A Look at What’s Ahead in Breast Cancer Care

Host: Matt Birnholz, MD Guest: Lauren Nye, MD Considering there’s little known about the breast microenvironment during pregnancy and whether this plays into future breast cancer risk, Dr. Lauren Nye's team examined whether omega 3 supplements as potential non-teratogenic chemoprevention agents could accentuate the protective changes on breast cancer risk that occur with hormonal fluctuations during pregnancy. And Dr. Matt Birnholz was there at the 2019 San Antonio Breast Cancer Symposium to catch up with Dr. Nye about this study.

New Perspectives on the Impact of Omega 3 Supplements on Breast Cancer Risk

Host: Matt Birnholz, MD Guest: Nadine Tung, MD Recorded live at the 2019 San Antonio Breast Cancer Symposium, Dr. Matt Birnholz sat down with Dr. Nadine Tung, Associate Professor of Medicine at Harvard Medical School and Director of the Cancer Risk and Prevention Program at Beth Israel Deaconess Medical Center, to talk about her presentation on genetic testing for hereditary breast cancer.

What to Look for When Testing for Hereditary Breast Cancer

Host: Matt Birnholz, MD Guest: Marina Kaplan, PhD Ms. Marina Kaplan's inspiring life history as an "outlier survivor" as she put it for having achieved remission from triple-negative breast cancer over six years ago was helped by numerous cutting-edge clinical trials made accessible to her. But the experience as a study subject exposed her to systemic barriers confronting breast cancer patients everywhere, compelling her to reprise her epidemiology career expertise in conducting a study looking for novel solutions, as she shares with Dr. Matt Birnholz at the 2019 San Antonio Breast Cancer Symposium.

An Outlier Survivor’s Story: Confronting Systemic Barriers in Breast Cancer Care

Host: Matt Birnholz, MD Guest: Daniela Rosa, MD To learn more about the effects of dietary interventions after early breast cancer treatment and the current gaps that exist in systemic reviews that assess those effects, Dr. Matt Birnholz sat down with Dr. Daniela Rosa at the 2019 San Antonio Breast Cancer Symposium.

The Effects of Dietary Interventions After Early Breast Cancer Treatment

Host: Matt Birnholz, MD Guest: Stephen Hiscox, PhD Though statins have long been used for the treatment of hypercholesterolemia, growing evidence suggests they may also have a role in lowering the risk of breast cancer development. But how they potentially do this and whether all statins are equal to that task was the focus of Dr. Matt Birnholz’s discussion with Dr. Stephen Hiscox at the 2019 San Antonio Breast Cancer Symposium.

Linking Statins to the Suppression of Aggressive Phenotypes of Triple-Negative Breast Cancer Cells

Host: Matt Birnholz, MD Guest: Dawn L. Hershman, MD, MS Much of the focus on endocrine therapy tends to be around future directions and what new treatments are going to accelerate care for breast cancer patients. But oncologists need to take stock of how physically and financially costly it can be, as Dr. Dawn Hershman explains to Dr. Matt Birnholz at the 2019 San Antonio Breast Cancer Symposium.

The Steep Toll of Endocrine Therapy on Breast Cancer Patients

Host: Nicola A. Hanania, MD, MS, FCCP Guest: Neil J. Freedman, MD Coming from the 2019 annual CHEST conference in New Orleans, Dr. Nicola Hanania joins Dr. Neil Freedman to discuss the advances in the diagnosis and treatment of COPD as well as the updated GOLD guidelines that were covered at the conference.

What’s New in COPD Care: Updates to the GOLD Guidelines & Other Advances

Host: Nicola A. Hanania, MD, MS Guest: Neil J. Freedman, MD Coming from the 2019 annual CHEST conference in New Orleans, Dr. Nicola Hanania joins Dr. Neil Freedman to discuss the advances in the diagnosis and treatment of COPD as well as the updated GOLD guidelines that were covered at the conference.

Guest: Nicola A. Hanania, MD, MS Guest: Reynold A. Panettieri Jr., MD Despite recent advances in management, many patients still experience uncontrolled or poorly controlled asthma. To keep you up to date on those emerging treatment options, this expert discussion will review patient- and practice-focused data presented during ACAAI 2019.

Advances in Severe Asthma: Highlights from ACAAI 2019

Host: Sandhya Khurana, MD, FCCP Guest: Monica Kraft, MD, FCCP Recorded live at the 2019 annual CHEST conference in New Orleans, Dr. Monica Kraft joins Dr. Sandhya Khurana to talk about how the new available biologics are going to fit into the severe asthma treatment landscape along with other highlights from the conference. Find out what Dr. Khurana and Dr. Kraft think you should do right now to improve treatment of severe asthma! This episode is supported in part by an unrestricted/independent medical educational grants from the following: Genentech, GlaxoSmithKline, and Novartis Pharmaceuticals Corporation. 

Singling Out Severe Asthma: New Breakthroughs in Treatment

ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.

hubhopper

Conference Coverage

hubhopper